“It’s extremely expensive to translate a patent into bedside medical tools,” Myriad Genetics president Mark C. Capone said in a telephone interview.
“It’s extremely expensive to translate a patent into bedside medical tools,” Myriad Genetics president Mark C. Capone said in a telephone interview.
“It’s extremely expensive to translate a patent into bedside medical tools,” Myriad Genetics president Mark C. Capone said in a telephone interview.

Supreme Court to consider whether firms can patent genes, the essence of life

April 12, 2013 5:22 PM

More Videos

  • Trump denies account of call with soldier's widow

    President Donald Trump denied telling the widow of Sgt. La David Johnson the serviceman "must have known what he signed up for" — a claim made by Florida Rep. Frederica Wilson, who was present for the call.